BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8638930)

  • 1. Simultaneous isolation of endogenous digoxin-like immunoreactive factor, ouabain-like factor, and deglycosylated congeners from mammalian tissues.
    Qazzaz HM; Valdes R
    Arch Biochem Biophys; 1996 Apr; 328(1):193-200. PubMed ID: 8638930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deglycosylated products of endogenous digoxin-like immunoreactive factor in mammalian tissue.
    Qazzaz HM; Goudy SL; Valdes R
    J Biol Chem; 1996 Apr; 271(15):8731-7. PubMed ID: 8621507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation of digoxin-like immunoreactive factors from mammalian adrenal cortex.
    Shaikh IM; Lau BW; Siegfried BA; Valdes R
    J Biol Chem; 1991 Jul; 266(21):13672-8. PubMed ID: 1856201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for presence of a reduced form of digoxin-like immunoreactive factor (dihydro-DLIF) in mammalian tissues.
    Qazzaz HM; Jortani SA; Poole JM; Valdes R
    Clin Chem; 1996 Jul; 42(7):1092-9. PubMed ID: 8674194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secretion of a lactone-hydrogenated ouabain-like effector of sodium, potassium-adenosine triphosphatase activity by adrenal cells.
    Qazzaz HM; El-Masri MA; Valdes R
    Endocrinology; 2000 Sep; 141(9):3200-9. PubMed ID: 10965891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human adrenal cells in culture produce both ouabain-like and dihydroouabain-like factors.
    el-Masri MA; Clark BJ; Qazzaz HM; Valdes R
    Clin Chem; 2002 Oct; 48(10):1720-30. PubMed ID: 12324489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of endogenous digitalis-like immunoreactive factors in human blood.
    Lin MH; Liao CP; Lee JS; Chin YW; Hsu CC; Wei JS
    Proc Natl Sci Counc Repub China B; 1998 Jul; 22(3):129-35. PubMed ID: 9779602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ouabain-like factor quantification in mammalian tissues and plasma: comparison of two independent assays.
    Ferrandi M; Manunta P; Balzan S; Hamlyn JM; Bianchi G; Ferrari P
    Hypertension; 1997 Oct; 30(4):886-96. PubMed ID: 9336389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mammalian cardenolides in cancer prevention and therapeutics.
    Al-Ghoul M; Valdes R
    Ther Drug Monit; 2008 Apr; 30(2):234-8. PubMed ID: 18367987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and preliminary characterization of two human digitalis-like substances that are structurally related to digoxin and ouabain.
    Weinberg U; Dolev S; Werber MM; Shapiro MS; Shilo L; Shenkman L
    Biochem Biophys Res Commun; 1992 Nov; 188(3):1024-9. PubMed ID: 1445339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal antibodies that distinguish between two related digitalis glycosides, ouabain and digoxin.
    Parhami-Seren B; Bell C; Margolies MN; Haupert GT
    J Immunol; 1999 Oct; 163(8):4360-6. PubMed ID: 10510376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of human serum with sulfosalicylic acid structurally alters digoxin and endogenous digoxin-like immunoreactive factor.
    Qazzaz HM; Goudy S; Miller JJ; Valdes R
    Ther Drug Monit; 1995 Feb; 17(1):53-9. PubMed ID: 7725377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Digoxinlike immunoreactive factor isolated from human pleural fluid is structurally similar to digoxin.
    Weinberg U; Dolev S; Shapiro MS; Shilo L; Rabinowitz R; Shenkman L
    Am J Med Sci; 1997 Jul; 314(1):28-30. PubMed ID: 9216437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Digoxin and its related endogenous factors.
    Jortani SA; Valdes R
    Crit Rev Clin Lab Sci; 1997; 34(3):225-74. PubMed ID: 9226105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Digoxin-like immunoreactive factors induce apoptosis in human acute T-cell lymphoblastic leukemia.
    Ihenetu K; Qazzaz HM; Crespo F; Fernandez-Botran R; Valdes R
    Clin Chem; 2007 Jul; 53(7):1315-22. PubMed ID: 17495020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. De novo biosynthesis and radiolabeling of mammalian digitalis-like factors.
    Qazzaz HM; Cao Z; Bolanowski DD; Clark BJ; Valdes R
    Clin Chem; 2004 Mar; 50(3):612-20. PubMed ID: 14981028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A physician's office-based digoxin assay (Seralyzer) evaluated for interference by endogenous digoxin-like immunoreactive factors.
    Matheke ML; Valdes R
    Ann Clin Lab Sci; 1989; 19(3):168-74. PubMed ID: 2658726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ouabain-like factors in human urine: identification of a Na-K-ATPase inhibitor as vanadium-diascorbate adduct.
    Kramer HJ; Krampitz G; Bäcker A; Meyer-Lehnert H
    Clin Exp Hypertens; 1998; 20(5-6):557-71. PubMed ID: 9682912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the ouabain-like factor and Na-K pump in rat and human genetic hypertension.
    Ferrandi M; Manunta P; Rivera R; Bianchi G; Ferrari P
    Clin Exp Hypertens; 1998; 20(5-6):629-39. PubMed ID: 9682919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methods for eliminating interferences in digoxin immunoassays caused by digoxin-like factors.
    Graves SW; Sharma K; Chandler AB
    Clin Chem; 1986 Aug; 32(8):1506-9. PubMed ID: 3755385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.